Brown Assistant Professor Theresa Raimondo has been chosen one of eight inaugural members of the Early Career Board (ECB) of ACS Applied Bio Materials. The recognition as an ECB member reflects Raimondo’s outstanding contributions to the biomaterials field and potential as a future leader in the academic community. ECB members will participate in the journal’s commissioning efforts and contribute to the journal content, social media engagement, and peer review process.
ACS Applied Bio Materials publishes original research covering all aspects of biomaterials and biointerfaces including and beyond the traditional biosensing, biomedical, and therapeutic applications.The journal reports new and original experimental and theoretical research of an applied nature that integrate knowledge in the areas of materials, engineering, physics, bioscience, and chemistry into important bioapplications.
“I am honored to be an Early Career Board member of ACS Applied Bio Materials. Biomaterials play an integral role in our ability to recapitulate chemical and mechanical cues in ex vivo systems and as targeted drug delivery vectors,” Raimondo said. “I look forward to building relationships throughout the ACS Applied Materials & Interfaces portfolio family and meaningfully contributing to the direction of ACS Applied Bio Materials.”
Aside from her appointment in engineering, Raimondo holds a second appointment in the Division of Biology and Medicine. She is a member of the Legorreta Cancer Center and the Brown RNA Center. Raimondo’s research centers around the design of targeted drug-delivery vectors and novel RNA-therapeutics for immunoengineering, cancer, and tissue regeneration. She has four filed patents surrounding targeted RNA-LNPs, adjuvanted vaccines, and siRNA-immunotherapy.
Raimondo received her postdoctoral training with Dr. Daniel Anderson and Dr. Robert Langer at the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology. She did her graduate work on the development of immune-modulating gold nanoparticles and hydrogels for muscle regeneration with Dr. David Mooney, receiving a Ph.D. in Engineering Sciences – Bioengineering from Harvard University in 2019. She received her Sc.B. in Chemical and Biochemical Engineering from Brown University in 2011.
Raimondo has been the recipient of several awards including the Northeast Bioengineering Conference Faculty Innovator Award, MIT Faculty Founder competition finalist, and the American Cancer Society-Institutional Research Grant.